Drawing for EMBRYONEST

USPTO serial 99666553

EMBRYONEST

Reviewed by CopyMark Law Group

Status 681
Filing date
Status date
Registration date
—
Examiner
MITROS, CATHERINE SUZANNE
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with EMBRYONEST?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Katherine E. Sieve

Katherine E. Sieve Polsinelli PCPO BOX 140310Kansas City, MO 64114-0310United States

Goods and services

ClassDescriptionStatusFirst use
001Synthetic bioactive hydrogels for use in laboratory research and the optimization of embryo growth for research purposes; hydrogel-based substrates for use in the screening and testing of embryo culture media and reagents in a laboratory setting for research purposes; chemical preparations for use in the manufacture of embryo culturing surfacesACTIVE—
005Medical preparations for use in assisted reproductive technology (ART) and in vitro fertilization (IVF), namely, bioactive hydrogels used as an embryo culture substrate to facilitate development and enhance embryo implantation competency; Clinical medical reagents for priming human embryos to increase clinical success rates in IVF procedures.ACTIVE—
009Cell culture apparatus for laboratory use, namely, plates having multi-well arrays pre-treated with hydrogel for the nurturing and monitoring of human embryosACTIVE—
010Medical devices for use in in vitro fertilization (IVF) procedures, namely, embryo culture dishes containing a bioactive hydrogel substrate; cell culture apparatus for medical use, namely, specialized multi-well plates pre-treated with hydrogel for the nurturing and monitoring of human embryosACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 4, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 13, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 21, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 21, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 21, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 29, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 29, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 29, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 22, 2026DOCKASSIGNED TO EXAMINER—
Jun 21, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 23, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Feb 23, 2026NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance